Jun 24 2025. Selected for the National New Drug Development Project.
- leelabsup
- 7월 2일
- 1분 분량
The project to develop a treatment for alcoholic liver disease using a ZBP1 inhibitor has been selected for support by the Korea Drug Development Fund (KDDF).
Originally noted for its ability to control cytokine storms in COVID-19, the ZBP1 inhibitor is now expected to gain momentum as a potential treatment for alcoholic liver disease.

06.24.2025 Press release : https://news.unist.ac.kr/kor/20250624-2/
Comments